Back to search
FDAFDA · Food and drugs·Recall number D-0881-2022

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

Published May 25, 2022 · Recall initiated: May 3, 2022

Summary

FDA records drug Class III recall D-0881-2022, published May 25, 2022 and initiated May 3, 2022. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 2353 bottles; Lot: Lot: RZ1598, exp. date 02/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email if SIROLIMUS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SIROLIMUS
Manufacturer
Apotex Corp.
Distributor
Nationwide in the USA
Lot
Lot: RZ1598, exp. date 02/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2 recalled?

Yes. FDA published recall D-0881-2022 on May 25, 2022. Reported hazard: Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SIROLIMUS.